Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy

Background: The 7+3 regimen is still the main choice of remission induction chemotherapy in acute myeloid leukemia (AML). Successfully achieving complete remission (CR) and the time required to achieve it determine patient’s survival. Hence, bone marrow examination on 14 (th) day of chemotherapy is...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadisantoso, Dwi Wahyunianto, Ranuhardy, Dody, Rajabto, Wulyo, Rizka, Aulia, Setiawan, Lyana, Rinaldi, Ikhwan, Mansjoer, Arif, Nelwan, Erni Juwita, Shatri, Hamzah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194516/
https://www.ncbi.nlm.nih.gov/pubmed/35721596
http://dx.doi.org/10.12688/f1000research.110320.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194516/
https://www.ncbi.nlm.nih.gov/pubmed/35721596
http://dx.doi.org/10.12688/f1000research.110320.2

Ejemplares similares